Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-24 @ 6:03 AM
Study NCT ID:
NCT05172466
Status:
WITHDRAWN
Last Update Posted:
2022-11-25
First Post:
2021-11-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY-20-02068
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None